SHMT catalyzes serine and glycine interconversion to provide essential methyl groups, whereas MTHFD1 produces critical folate intermediates.232 Abnormalities in these enzymatic steps can disrupt methylation homeostasis, linking metabolic reprogramming to dynamic cancer epigenomic changes. Here, SHMT2 is linked to cancer.